or
Bookmark and Share
BENZOTHIAZINE DIOXIDES AS ANTI-THROMOBOTIC AGENTS
   
Document Number
US Patent 3862319
Issued Date
January 21, 1975
Link
Inventors
Map
Abstract
Certain 3,4-dihydro-4-oxo and 3-oxo-2H-1,2-benzothiazine-3-carboxamide and 4-carboxamide 1,1-dioxide compounds effective in the treatment of thrombosis are disclosed.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
22
Comments:
no comments yet
Owner
Pfizer Inc. (New York, NY)
Published
January 21, 1975
Application Number
05/362,518
Filed
May 21, 1973
US Classification
514/226.5   514/822 544/50
Int'l Classification
C07D   279/00   (20060101)   C07D   279/02   (20060101)  
Attorney/Law Firm
Parent Case
CROSS-REFERENCE TO RELATED APPLICATIONS The subject application is a continuation-in-part of co-pending application Ser. No. 114,037, filed Feb. 9, 1971, now abandoned said application Ser. No. 114,037 in turn being a continuation of application Ser. No. 829,713, filed June 2, 1969, and now abandoned.
USPTO Field of Search
260/243   424/246  
Related Patents
4540692 - Anti-inflammatory N-(1-oxo-2,4,6-cycloheptatrienyl)2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use - Owned by Fujisawa Pharmaceutical Co., Ltd. (Osaka,JP)

The invention relates to novel tropone derivatives, of antiinflammatory, analgesic and antirheumatic activity, of the formula: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl, R.sup.2 is hydrogen, hydroxy, halogen, lower alkyl, or lower alkoxy, and R.sup.3 is hydrogen or acyl, and pharmaceutically acceptable salts thereof.

4761424 - Enolamides, pharmaceutical compositions and methods for treating inflammation - Owned by Warner-Lambert Company (Morris Plains, NJ)

The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us